In addition, TET2, AML1, and TP53 mutations were identified in the pericardial effusion cells and the BM cells, forming the hypothesis that these mutations may participate in a common pathway to the pathogenesis of T-LBL and MS [33]. This evidence concerns the gene RUNX1 and myeloid sarcoma.